YUN CHAE OK has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and electrical machinery and energy are IFOM FONDAZIONE ST FIRC DI ONCOLOGIA MOLECOLARE, ISLETONE AB and GENOMIDEA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 6 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Electrical machinery and energy | |
#4 | Telecommunications | |
#5 | Mechanical elements | |
#6 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Machines for making railways | |
#6 | Frames | |
#7 | Non-portable lighting devices | |
#8 | Telephonic communication |
# | Name | Total Patents |
---|---|---|
#1 | Yun Chae Ok | 10 |
#2 | Kim Joo Hang | 5 |
#3 | Lee Jung-Sun | 2 |
#4 | Shin Hyun Chul | 1 |
#5 | Yoon A-Rum | 1 |
#6 | Kim Joo-Hang | 1 |
#7 | Kang Yoon A | 1 |
#8 | Lee Jung Sun | 1 |
#9 | Kim Jin Soo | 1 |
#10 | Yun Chae-Ok | 1 |
Publication | Filing date | Title |
---|---|---|
KR20130019847A | Anti-cancer compositions containing wnt decoy receptor | |
KR20070078580A | Recombinant adenoviruses capable of regulating angiogenesis | |
KR20070042283A | Recombinant adenovirus expressing vegf-aspecific si rna with enhanced oncolytic activity | |
KR20060094630A | Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system | |
KR20050107646A | Recombinant Adenoviruses with Defective Rb-Binding Capacity Exhibiting Improved Tumor Cell-Specific Cytotoxicity | |
WO03029448A1 | Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |